https://news.augustaheadlines.com/story/455848/alexander-arshavski-launches-revolutionary-guide-to-mastering-remote-work-work-from-home-like-a-pro.html 2024-02-12T17:03:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/455977/shanel-evans-appointed-as-new-ambassador-for-the-virginia-black-chamber-of-commerce.html 2024-02-12T17:02:07+00:00 daily 1.0 https://news.augustaheadlines.com/story/455976/poets-and-profits-salute-to-singersongwriter-jackie-deshannon-saturday-afternoon-april-6-2024-at-the-country-music-hall-of-fame-museum.html 2024-02-12T17:00:05+00:00 daily 1.0 https://news.augustaheadlines.com/story/455975/therafoot-pro-launches-ems-foot-massager-for-neuropathy-pain-relief.html 2024-02-12T16:58:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/455974/fourseemarketing-revolutinizes-the-culinary-experience-and-transforming-cooking-through-ultimate-kitchen-essentials-collection.html 2024-02-12T16:54:05+00:00 daily 1.0 https://news.augustaheadlines.com/story/455973/psychosis-in-parkinsons-disease-and-alzheimers-disease-market-to-witness-upsurge-in-growth-during-the-forecast-period-20232032-examine-delveinsight-sunovion-pharma-merck-vanda-pharma.html 2024-02-12T16:52:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/455846/hot-mess-consulting-is-designing-brands-with-purpose-and-precision-for-the-retail-fashion-ecommerce-industry.html 2024-02-12T16:51:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/455972/non-muscle-invasive-bladder-cancer-pipeline-drugs-analysis-report-2024-fda-approvals-clinical-trials-therapies-moa-roa-by-delveinsight-aura-biosciences-protara-therapeutics-vaxiion.html 2024-02-12T16:48:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/455971/dry-eye-disease-pipeline-drugs-analysis-report-2024-updates-fda-approvals-clinical-trials-therapies-moa-roa-by-delveinsight-abbvie-allergan-aft-pharma-akorn-alcon-inc-bausch-health.html 2024-02-12T16:46:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/455970/type-2-diabetes-pipeline-drugs-analysis-report-2024-fda-approvals-clinical-trials-therapies-mao-roa-by-delveinsight-ionis-pharma-eli-lilly-oramed-pharma-astrazeneca-novo-nordisk-jiangsu.html 2024-02-12T16:44:03+00:00 daily 1.0